Skip to main content
. 2015 Dec 15;17:972–981. doi: 10.1007/s12094-015-1434-4

Fig. 2.

Fig. 2

Therapeutic strategies in advanced colorectal cancer. Patients appropriate for intensive therapy. Note Front line treatment should consider clinical symptoms, comorbid conditions, prior adjuvant therapy, tumor biology and dynamics, and potential ability for metastasis resection. BV bevacizumab, XELOX oxaliplatin + capecitabine, FOLFOX biweekly oxaliplatin + infusional 5FU/LV, FOLFIRI biweekly irinotecan + infusional 5FU/LV, wt wild type. *If available